The Market

Heart condition graph-2

3 million people die annually of sudden cardiac death – 100,000 in the UK alone.  These deaths could be prevented with a device called an Implantable Cardioverter Defibrillator (ICD), inserted during a minor operation.

However, it is very difficult to work out who needs an ICD because current risk markers for sudden cardiac death are limited.  This has led NICE (National Institute for health and Care Excellence) to call for research into new risk markers.

A large number of people could benefit from having a LifeMap™ test to accurately assess their risk of sudden cardiac death. Each year 32 million people suffer a heart attack that puts them at high risk of sudden cardiac death, 1.5 million in America alone. There are many millions of people living with other conditions that put them at risk of sudden cardiac death; risk assessment for these people is even more limited at present.

LifeMap has additionally been shown to precisely assess need for ICD in patients with all of these conditions.

About Us

LifeMap diagnostics is based in Leicester, UK and includes a team of researchers and clinicians.

What is LifeMap?

LifeMap is a quick, minimally invasive test that has been shown to precisely assess risk of sudden cardiac death.

LifeMap Success

LifeMap has won numerous awards and Research Grants because of its novelty and efficacy.

Evidence for LifeMap?

LifeMap has been detailed in 3 peer reviewed published studies with further publications being finalised.